Lv21
110 积分 2024-12-23 加入
Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor
4小时前
已完结
From TCR fundamental research to innovative chimeric antigen receptor design
6天前
已完结
The roles of arginases and arginine in immunity
19天前
已完结
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
1个月前
已完结
Regulated induced proximity targeting chimeras—RIPTACs—A heterobifunctional small molecule strategy for cancer selective therapies
1个月前
已完结
Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance
1个月前
已完结
Small molecule interleukin 17A/A antagonists and antibodies blocking both IL17A/A & IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammation
1个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
1个月前
已完结
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds
1个月前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
